Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vita Life Sciences Limited ( (AU:VLS) ) has shared an update.
Vita Life Sciences Limited has announced an update on its ongoing on-market buy-back program. As of September 18, 2025, the company has bought back a total of 202,701 ordinary fully paid securities, including 6,960 securities purchased on the previous day. This buy-back initiative is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the development and distribution of nutritional and healthcare products. The company is known for its range of vitamins, supplements, and other health-related products, catering to a diverse market seeking wellness solutions.
Average Trading Volume: 13,088
Technical Sentiment Signal: Buy
Current Market Cap: A$133.1M
See more insights into VLS stock on TipRanks’ Stock Analysis page.